Encodia
Initial Transaction Details
Transaction Date
December 2020
Purpose of Financing
Venture
Stage of Company
Early Stage
Structure of Financing
Equity
Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company’s patented ProteoCode technology enables highly scalable protein analysis via an accessible and easy-to-use benchtop instrument. Tools employing Encodia’s ProteoCode technology will drive new biological understanding with impact in data-driven drug discovery and development, new high complexity diagnostics, and beyond.
Website